Immunofluorescence labelling with anti‐CD31 and anti‐αSMA confirmed a higher number of arterioles (CD31+ and αSMA+) for VEGF222/NF compared with control tumours (P < 0.05, Fig. 3G,H). This evidence concerns the gene NFASC and neoplasm.